TUBEROUS SCLEROSIS COMPLEX
Clinical trials for TUBEROUS SCLEROSIS COMPLEX explained in plain language.
Never miss a new study
Get alerted when new TUBEROUS SCLEROSIS COMPLEX trials appear
Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
TSC seizure drug safety tracked over years
Disease control OngoingThis study looks at the long-term safety of the drug everolimus in people with tuberous sclerosis complex (TSC) who have seizures that are hard to control. Participants are already taking everolimus and benefiting from it in an earlier study. The main goal is to track side effect…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New hope for Hard-to-Treat seizures: experimental drug radiprodil enters human testing
Symptom relief OngoingThis study tests an experimental drug called radiprodil in 30 people with tuberous sclerosis complex (TSC) or focal cortical dysplasia (FCD) type II whose seizures have not improved with at least two other medications. The main goals are to check the drug's safety and how the bod…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE1, PHASE2 • Sponsor: GRIN Therapeutics, Inc. • Aim: Symptom relief
Last updated May 17, 2026 02:53 UTC
-
Epidiolex liver check: no alarm, just monitoring
Knowledge-focused OngoingThis study watches for possible long-term liver damage in 154 people already taking or starting Epidiolex for certain seizure disorders. Researchers will use blood tests and special scans to check for liver scarring over time. The goal is to understand if the drug can cause chron…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Knowledge-focused
Last updated May 17, 2026 02:57 UTC
-
Can a PET scan predict drug response in rare lung disease?
Knowledge-focused OngoingThis study explores whether a special PET scan using [11C]acetate can detect early signs that the drug rapamycin is working in people with lymphangioleiomyomatosis (LAM), a rare lung disease. Seven adults with LAM and at least one kidney tumor will receive one or two PET scans ov…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX
Phase: PHASE1, PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 05, 2026 11:53 UTC